Patent · US Active

Organic compounds

US9469625B2 · kind B2 · utility

2Cited by
2References
34Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 22, 2012
Grant dateOct 18, 2016
Priority date
Expiry dateJun 22, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to compounds and methods of treatment relating to nicotinic receptor antagonists. For example, the compounds and methods of treatment function block the activity of certain acetylcholine receptors and subtypes therein, and are useful treating diseases and conditions mediated by nicotinic receptor stimulation, e.g., small cell lung cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.